Author: Rob Stein
Rob Stein
has 52.5% among authors.
BS Score: 3.2%.
Articles analyzed: 5.
Words analyzed: 12,356.
Analyzed articles
NPR
- By Rob Stein
- 6/11/2026, 5:42 PM
Negativity Bias 34.2% - Availability Heuristic 14.2% - Framing Effect 13.9%
The Trump administration has imposed some very tough measures in response to the hantavirus and Ebola outbreaks, despite the president's past history of criticizing COVID-19 restrictions during the pandemic. "They have spent so much time talking about not having the government impose on peoples individual decisions and individual... more
NPR
- By Rob Stein
- 5/3/2026, 9:09 PM
Overconfidence Bias 28.3% - Confirmation Bias 18.6% - Ambiguity (Equivocation) 16.3%
Investigators have recovered a buckshot pellet from the bulletproof vest worn by a Secret Service agent who was shot at the White House Correspondents' Dinner, according to Jeanine Pirro, the U.S. attorney for the District of Columbia. The pellet links the suspect, Cole Tomas Allen, 31, of Torrance, Calif., to the attack, Pirro told CNN... more
NPR
- By Pien Huang, Rob Stein, Carmel Wroth
- 12/5/2025, 4:20 PM
In a historic vote, the Centers for Disease Control and Prevention's vaccine advisers recommended narrowing the agency's hepatitis B immunization guidance for newborns. The result, if approved by the CDC's acting director, will be a rollback of a universal recommendation to start hepatitis B immunization at birth, a standard practice in... more
NPR
- By Rob Stein
- 5/22/2025, 8:49 PM
The companies that make COVID-19 vaccines should update the shots again to target a variant closer to the strains currently on the rise, a committee of independent advisers to the Food and Drug Administration unanimously recommended Thursday. Moderna, Pfizer/BioNTech and Novavax should target strains related to the JN.1 variant with... more
NPR
- By Rob Stein
- 5/20/2025, 8:12 PM
The Food and Drug Administration is taking a new approach to COVID-19 vaccines that would prioritize immunizations for people at highest risk for serious complications from the disease but could make it harder for many other people to get the shots. The new strategy would continue the current vaccine approval process for people ages 65... more